Fiduciary Trust CO Logic Bio Therapeutics, Inc. Transaction History

Fiduciary Trust CO

  • $6.5 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022
BUY
$0.61 - $2.49 $6,100 - $24,900
10,000 Added 26.32%
47,998 $33,000
Q1 2020

May 15, 2020
BUY
$4.06 - $11.0 $28,411 - $76,978
6,998 Added 22.57%
37,998 $188,000
Q4 2019

Feb 04, 2020
BUY
$7.01 - $11.01 $217,310 - $341,310
31,000 New
31,000 $223,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email